Keywords: aveo, biogen, alliance, erbb3-targeted, antibodies, pharmaceuticals, signed

AVEO and Biogen alliance for ErbB3-targeted antibodies

Article | 30 March 2009

AVEO Pharmaceuticals has signed a definitive agreement with fellow USA-based Biogen Idec, for the development and commercialization of the former's ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Biogen Idec

Go to company listing